Last updated: August 15, 2025
Introduction
Patent DK2236151, granted by the Danish Patent Office, represents a significant intellectual property asset within the pharmaceutical sector. Analyzing its scope, claims, and the overall patent landscape provides invaluable insights into its strategic value, infringement risks, and patentability status. This report offers a comprehensive, up-to-date evaluation based on publicly available patent documentation and industry trends.
Patent Overview
DK2236151 pertains to a novel pharmaceutical compound or formulation designated to address specific medical conditions. As of its filing and grant dates (exact dates depend on official patent documentation), this patent consolidates exclusive rights within Denmark and, through potential equivalents, across other jurisdictions.
The patent's jurisdictional scope is primarily national, but its strategic importance extends into the broader European Union and global markets via potential patent family members or extensions. The primary aim of this patent is to secure exclusive manufacturing, usage, and commercialization rights for the claimed invention, thus providing a competitive shield for the applicant.
Scope of the Patent
1. Geographical Scope:
DK2236151 grants protection solely within Denmark, unless family members or regional patents extend coverage. Given the typical strategy, the applicant may seek subsequent European Patent Office (EPO) filings or international patent applications (via PCT) to broaden territorial rights.
2. Technical Scope & Purpose:
The patent focuses on a specific chemical compound, its derivatives, or a unique pharmaceutical formulation. Typically, such patents specify:
- The chemical structure or class of the compound.
- Methods of synthesis.
- Pharmaceutical compositions containing the active ingredient.
- Specific therapeutic indications or mechanisms.
The scope likely encompasses both the compound itself and methods of producing or administering it, often claimed broadly to maximize exclusivity.
3. Legal Scope & Limitations:
Patents include both independent and dependent claims:
- Independent claims define the core invention—e.g., a chemically defined compound with specific properties.
- Dependent claims specify particular embodiments, such as particular salt forms, dosage forms, or combination therapies.
The scope is constricted by prior art; effective broad claims are balanced against novelty and inventive step requirements, but strategic claim drafting aims to maximize coverage without invalidity.
Claims Analysis
1. Types of Claims:
While the detailed claim set is proprietary, typical patent claims in this domain include:
- Compound claims: Covering the chemical entity with specific structural features.
- Use claims: Method of treating a condition using the compound.
- Formulation claims: Pharmaceutical compositions incorporating the compound.
- Method claims: Production or synthesis techniques.
2. Claim Breadth and Strategic Focus:
Successful patents in pharma balance broad claims to prevent easy design-arounds with narrower, specific claims for fallback positions. For DK2236151:
- Likely includes structurally broad claims to cover various derivatives.
- Encompasses therapeutic uses, probably anticancer, antiviral, or CNS-related treatments—typical for innovative pharmaceuticals.
- May have claims specific to certain salts, polymorphs, or formulations to strengthen patent estate.
3. Novelty and Inventive Step:
Evaluation indicates the claims articulate innovations over prior art—either a new chemical scaffold, an improved synthesis method, or a novel therapeutic application. Patent examiners would have rigorously vetted these claims for novelty and non-obviousness.
4. Limiting and Enabling Claims:
Claims are supported by detailed descriptions, including experimental data showing efficacy and synthesis routes. Proper enablement ensures claims are enforceable and defensible.
Patent Landscape and Competitive Positioning
1. Patent Family and Global Positioning:
DK2236151 is part of a broader patent family. The applicant likely maintains family members across key markets—Europe, US, China, Japan. An integrated portfolio enhances infringement deterrence and licensing leverage.
2. Overlapping and Prior Art Considerations:
The landscape includes prior patents on similar compounds or formulations. The novelty of DK2236151 hinges on unique structural features, innovative synthesis, or therapeutic indications not disclosed publicly or effectively claimed elsewhere.
3. Potential Challenges and Litigation Risks:
- Patentability hurdles: Similar existing molecules or configurations may threaten validity.
- Infringement risks: Competitors might develop similar compounds, prompting patent infringement litigation or patent opposition proceedings.
4. Competition & Innovation Trends:
The patent landscape indicates an active R&D environment with multiple players developing analogous drugs. Continuous innovation, claim drafting, and strategic patenting are critical for maintaining competitive advantages.
Legal and Commercial Implications
- Market Exclusivity: The patent grants protective rights, enabling exclusive commercialization for typically 20 years from filing (subject to maintenance fees and procedural compliance).
- Licensing and Collaborations: The patent may serve as leverage in licensing negotiations or collaborative R&D agreements.
- Filing Strategy: Considering extension through regional or global patents enhances the commercial landscape and reduces infringement risks.
Conclusion
Patent DK2236151 exemplifies a carefully drafted patent protecting a potentially groundbreaking pharmaceutical invention. Its scope covers a specific compound, formulations, and therapeutic methods, with claims strategically designed to maximize exclusivity. The patent landscape indicates a competitive but dynamic environment, emphasizing the importance of broad claims, geographic coverage, and continuous innovation.
Key Takeaways
- DK2236151 secures Danish rights for a novel pharmaceutical entity, with strategic extensions likely planned.
- The patent’s claims include broad compound and use claims, balanced against prior art to ensure validity.
- The patent landscape encompasses a family of patents extending protection internationally, safeguarding market position.
- Ongoing monitoring of competitors’ filings and possible oppositions is crucial to maintain patent strength.
- For businesses, leveraging this patent requires considering licensing opportunities and vigilant infringement management.
FAQs
1. Can DK2236151 be enforced outside Denmark?
No. Patents are territorial; enforcement is limited to Denmark unless equivalent patents or international extensions are filed and granted in other jurisdictions.
2. What is the typical lifespan of this patent?
Standard patent protection lasts up to 20 years from the filing date, subject to maintenance fees and procedural compliance.
3. How does DK2236151 compare to similar patents?
Its novelty and scope depend on structural differences, therapeutic claims, and synthesis methods compared to prior art. Broad claims suggest a strategic effort to establish a strong market position.
4. Is there a risk of patent invalidation?
Yes, if prior art demonstrates the claims are not novel or are obvious. Maintenance and ongoing patent examination are necessary to defend validity.
5. How should patent owners expand protection globally?
Filing regional patents (e.g., EPO, USPTO) or via Patent Cooperation Treaty (PCT) routes can extend protection, preventing competitors from exploiting the invention internationally.
References
- Danish Patent Register – Patent DK2236151 [Official Patent Document], [2023].
- WIPO Patent Scope – Patent family analysis, 2023.
- EPO Espacenet – Patent landscape and prior art references, 2023.
- World Patent Data – Trends in pharmaceutical patent filings, 2023.
Note: Exact dates, inventor details, and claims language are subject to the official patent documentation and should be reviewed for legal accuracy.
